Ad
related to: merck pharmaceuticals
Search results
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 7 days agoMerck’s venture arm was an investor in EyeBio. EyeBio’s lead drug, Restoret, is in development to...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 16 hours agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 1 day agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 6 days agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck to Acquire EyeBio
Morningstar· 7 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 7 days agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Merck nears $1.3 bln takeover of Eyebiotech- WSJ By Investing.com
Investing.com· 7 days agoMerck nears $1.3 bln takeover of Eyebiotech- WSJ
Merck to buy eye drug developer for $1.3B
BioPharma Dive via Yahoo Finance· 7 days agoAn acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 6 days agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
